`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`AKER BIOMARINE AS
`Petitioner
`
`v.
`
`NEPTUNE TECHNOLOGIES AND BIORESSOURCES INC.
`Patent Owner
`
`
`CASE IPR: Unassigned
`
`AKER BIOMARINE AS’S EXHIBIT LIST
` (INTER PARTES REVIEW OF U.S. PATENT NO. 8,278,351)
`
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`1
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`
`
`U.S. Pat. No. 8,278,351 to Sampalis (“’351”)
`
`WO 00/23546 to Beaudoin (“Beaudoin I”)
`
`Canadian Application 2,251,265 to Beaudoin (“Beaudoin II”)
`
`Certified translation of Ex. 1070: Japanese Unexamined Patent
`Application Publication No. 02-215351, titled Krill Phospholipids
`Fractioning Method (“Maruyama,”); Certificate of Translation
`provided as Ex. 1071.
`
`Certified translation of Ex. 1072: Fisheries Agency, General
`Report on Research and Development of Techniques in Processing
`and Utilization of Marine Products, Chapter 6, Development of
`technology for recovery of valuable substances (astaxanthin) from
`krill, by Takao Fujita, pp. 273-307 (March 1985) (“Fujita”) ;
`Certificate of Translation provided as Ex. 1073.
`
`Fricke et al., Lipid, Sterol, and Fatty Acid Composition of
`Antarctic Krill, Lipids, Vol. 19, No. 11, pp. 821-827 (1984)
`(“Fricke”)
`
`Bottino, N.R., “Lipid Composition of Two Species of Antarctic
`Krill: Euphausia Superba and E. Crystallorophias,” Comp.
`Biochem. Physiol., 1975, Vol. 50B, pp. 479-484 (“Bottino”)
`
`2
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`1014
`
`1015
`
`
`
`Canadian Patent No. 1098900, titled Method for the Processing of
`Krill to Produce Protein, Lipids and Chitin (“Rogozhin”)
`
`Itano Refrigerated Food Co., Ltd., Bio & High Technology
`Announcement and Natural Astaxanthin & Krill Lecithin, pp. 1-16
`(on or before December 28, 1994) (“Itano”)
`
`WO97/39759 to Stoll (“Stoll”)
`
`Final Prospectus dated May 11, 2001 (“Final Prospectus”)
`
`“Neptune Technologies & Bioressources Soon to Obtain a Major
`Patent in Over 30 Countries” (“2011 Press Release,”)
`
`Le Grandois et al., Investigation of Natural Phosphatidylholine
`Sources: Separation and Identification by Liquid Chromatography
`-Electrospray Ionization-Tandem Mass Spectrometry (LC-ESI-
`MS2) of Molecular Species, J. Agric. Food Chem., 57, 6014-20
`(2009) (“Le Grandois”)
`
`Certified translation of Ex. 1074: Japanese Patent No. 60-153779,
`entitled “Nutritional Supplement” (“Fukuoka ”); Certificate of
`Translation provided as Ex. 1075
`
`Certified translation of Ex. 1076: Japanese Patent Publication No.
`H08-231391, entitled “Medicine for Improvement of Dementia
`
`3
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`Symptoms” (“Yasawa”); Certificate of Translation provided as
`Ex. 1077.
`
`Suzuki, T. and Shibata, N., “The utilization of Antarctic krill for
`human food,” Food Rev. Int’l, 6:1, 119-147 (1990) (“Suzuki”)
`
`Bergelson (ed.), Lipid Biochemical Preparations, Chapter I.1, pp.
`1-13 (1980) (“Bergelson”)
`
`WHO News and Activities, Bulletin of the World Health
`Organization, 73(4), pp. 547-51 (1995) (“WHO Bulletin”)
`
`Bell and Dick, Molecular Species Composition of the Major
`Diacyl Glycerophospholipids from Muscle, Liver, Retina and
`Brain of Cod (Gadus morhua), Lipids, Vol. 26, No. 8, pp. 565-
`573 (1991) (“Bell and Dick”)
`
`Henderson et al., Lipid Composition of the Pineal Organ from
`Rainbow Trout (Oncorhynchus mykiss), Lipids, Vol. 29, No. 5,
`pp. 311-317 (1994) (“Henderson ”)
`
`Bell, Molecular Species Analysis of Phosphoglycerides from the
`Ripe Roes of Cod, Lipids, Vol. 24, No. 7 (1989)
`
`Takahashi et al., Compositional Changes in Molecular Species of
`Fish Muscle Phosphatidylcholine During Storage, Bull. Fac. Fish.
`
`4
`
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`Hokkaido Univ. 37(1), 80-84 1986.
`
`Takahashi et al., Prediction of Relative Retention Value of the
`Individual Molecular Species of Diacyl Glycerolipid on High
`Performance Liquid Chromatography, Bull. Fac. Fish. Hokkaido
`Univ. 38(4), 398-404. 1987
`
`Lin et al., Effect of Dietary N-3 Fatty Acids Upon the
`PhospholipidMolecular Species of the Monkey Retina, Invest
`Ophthalmol Vis Sci. 1994;35:794-803
`
`Farkas, Composition and Physical State of Phospholipids in
`Calanoid Copepods from India and Norway, LIPIDS, Vol. 23, No.
`6 (1988)
`
`Bell, Molecular Species Composition of Phosphatidylcholine from
`Crypthecodinium cohnii in Relation to Growth Temperature
`Lipids 25, 115-118 (1990)
`
`Buda, Structural order of membranes and composition of
`phospholipids in fish brain cells during thermal acclimatization,
`Proc. Natl. Acad. Sci. USA Vol. 91, pp. 8234-8238, August 1994
`
`Takahashi et al., Molecular Species of Fish Muscle Lecithin,
`Bulletin of the Japanese Society of Scientific Fisheries 48(12),
`
`5
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`1028
`
`
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1803-1814 (1982)
`
`1029
`
`1030
`
`1031
`
`1032
`
`1033
`
`1034
`
`1035
`
`Tocher, Chapter 6, Glycerophospholipid metabolism,
`Biochemistry and molecular biology of fishes, vol. 4, Hochachka
`and Mommsen (eds.)(1995)
`
`Tanaka, Biosynthesis of 1,2-dieicosapentaenoyl-sn-glycero-3-
`phosphocholine in Caenorhabditis elegans, Eur. J. Biochem. 263,
`189±194 (1999)
`
`Winther et al., Elucidation of Phosphatidylcholine Composition in
`Krill Oil Extracted from Euphausia superba, Lipids 46(1):25-36
`(2011)(“Winther”)
`
`Eichberg, “Lecithin – It Manufacture and Use in the Fat and Oil
`Industry,” Oils and Soap 51-54, 1939 (“Eichberg”)
`
`Balassa et al., Microencapsulation in the Food Industry, Critical
`Reviews in Food Technology, 2:2, 245-265 (1971)(“Balassa”)
`
`Buchi R-220 Rotovapor® Manual
`
`Johnson and Lucas, Comparison of Alternative Solvents for Oils
`Extraction, JAOCS 60(2):229-242 (1983)
`
`1036
`
`U.S. Pat. No. 4,714,571
`
`
`
`6
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`Grit et al., Int. J. Pharmaceutics 50:1-6 (1989)
`
`Herman and Groves, Pharmaceutical Research 10(5):774-776
`(1993)
`
`Watanabe et al., Effective Components in Cuttlefish Meal and
`Raw Krill for Improvement of Quality of Red Seabream Pagrus
`major Eggs, Nippon Suisan Gakkaishi 57(4):681-694
`(1991)(“Watanabe”)
`
`Declaration of Dr. Richard van Breemen in Support of Inter Partes
`Review of U.S. Pat. No. 8,278,351 (“Van Breemen”)
`
`Declaration of Dr. Suzanne Budge in Support of Inter Partes
`Review of U.S. Pat. No. 8,278,351 (“Budge”)
`
`Declaration of Dr. Thomas Brenna in support of Inter Partes
`Review of U.S. Pat. No. 8,278,351
`
`Expert Witness Report of Dr. Theodore Welch submitted in
`relation to ITC Investigation No. 337-TA-877 (“Welch”)
`
`Declaration of Dr. Jeff Moore in Support of Inter Partes Review of
`U.S. Pat. No. 8,278,351 (“Moore”)
`
`AKBM
`Exhibit No.
`
`1037
`
`1038
`
`1039
`
`1040
`
`1041
`
`1042
`
`1043
`
`1044
`
`1045
`
`Declaration of Dr. Albert Lee in Support of Inter Partes Review of
`
`
`
`7
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`U.S. Pat. No. 8,278,351 (“Lee”)
`
`Declaration of Dr. Ivar Storrø in support of Inter Partes Review of
`U.S. Pat. No. 8,278,351 (“Storrø”)
`
`Declaration of Bjorn Ole Haugsgjerd submitted during inter partes
`reexamination of parent patent U.S. 8,030,348 (“Haugsgjerd ‘348
`Decl.”)
`
`Supplemental Declaration of Bjorn Ole Haugsgjerd submitted
`during inter partes reexamination of parent patent U.S. 8,030,348
`(“Haugsgjerd ‘348 Supp. Decl.”)
`
`Declaration of Dr. Thomas Gundersen submitted during inter
`partes reexamination of parent patent U.S. 8,030,348 (“Gundersen
`Decl.”)
`
`Supplemental Declaration of Dr. Thomas Gundersen submitted
`during inter partes reexamination of parent patent U.S. 8,030,348
`(“Gundersen Supp. Decl.”)
`
`Declaration of Dr. Earl White submitted during prosecution of
`parent patent U.S. 8,030,348 (“2011 White Decl.”)
`
`Supplemental Declaration of Dr. Earl White submitted during
`prosecution of parent patent U.S. 8,278,351 (“White Supp. Decl.”)
`
`8
`
`1046
`
`1047
`
`1048
`
`1049
`
`1050
`
`1051
`
`1052
`
`
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1053
`
`1054
`
`1055
`
`1056
`
`1057
`
`1058
`
`1059
`
`1060
`
`
`
`Declaration of Dr. Jacek Jaczynski from inter partes reexamination
`of the parent patent U.S. 8,030,348 (“Jaczynski Reexam. Decl.”)
`
`Declaration of Dr. Yeboah submitted during inter partes
`reexamination of parent patent U.S. 8,030,348 (“Yeboah Reexam
`Decl.”)
`
`Supplemental Declaration of Dr. Earl White submitted during
`inter partes reexamination of parent patent U.S. 8,030,348 (“White
`Supp. Reexam. Decl.”)
`
`Declaration of Dr. Shahidi submitted during inter partes
`reexamination of parent patent U.S. 8,030,348 (Shahidi Reexam.
`Decl.”
`
`Declaration of Dr. Tina Sampalis submitted during inter partes
`reexamination of parent patent U.S. 8,030,348 (Sampalis”)
`
`Declaration of Dr. Yeboah submitted during prosecution of parent
`patent U.S. 8,278,351 (“Yeboah ‘351 Decl.”)
`
`Declaration of Dr. Shahidi submitted during prosecution of parent
`patent U.S. 8,278,351 (Shahidi ‘351 Decl.”)
`
`Declaration of Dr. Jaczynski submitted during prosecution of
`parent patent U.S. 8,278,351 (Jaczynski ‘351 Decl.”)
`
`9
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1061
`
`1062
`
`1063
`
`1064
`
`1065
`
`1066
`
`1067
`
`1068
`
`1069
`
`1070
`
`
`
`April 2, 2012 Response to Office Action, ‘351 patent
`
`Provisional Application No. 60/307,842 (Priority document for the
`‘351 patent)
`
`Office Action dated January 5, 2012, ‘351 patent
`
`Action Closing Prosecution, ‘348 patent
`
`Grant of Request for Ex parte Reexamination of the ‘351 patent
`
`Declaration of Dr. Van Breemen submitted during Ex parte
`Reexamination of the ‘351 patent (Van Breemen ‘351 Reexam.
`Decl.”
`
`Declaration of Dr. Van Breemen submitted during Inter partes
`Reexamination of the ‘348 patent (Van Breemen ‘348 Reexam
`Decl.”
`
`Medina et al., J. Amer. Oil Chem. Soc. 71(5):479-82 (1994)
`
`U.S. Patent No. 8,030,348
`
`Japanese Unexamined Patent Application Publication No. 02-
`215351, titled Krill Phospholipids Fractioning Method; Japanese
`language document
`
`10
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1071
`
`1072
`
`1073
`
`1074
`
`1075
`
`1076
`
`
`
`Certification of translation of Ex. 1070: Japanese Unexamined
`Patent Application Publication No. 02-215351
`
`Fisheries Agency, General Report on Research and Development
`of Techniques in Processing and Utilization of Marine Products,
`Chapter 6, Development of technology for recovery of valuable
`substances (astaxanthin) from krill, by Takao Fujita, pp. 273-307
`(March 1985); Japanese language document
`
`Certificate of translation of Ex. 1072: Fisheries Agency, General
`Report on Research and Development of Techniques in Processing
`and Utilization of Marine Products, Chapter 6, Development of
`technology for recovery of valuable substances (astaxanthin) from
`krill, by Takao Fujita, pp. 273-307 (March 1985); Japanese
`language document
`
`Japanese Patent No. 60-153779, entitled “Nutritional
`Supplement”; Japanese language document
`
`Certificate of translation of Ex. 1074: Japanese Patent No. 60-
`153779, entitled “Nutritional Supplement”
`
`Japanese Patent Publication No. H08-231391, entitled “Medicine
`for Improvement of Dementia Symptoms”; Japanese language
`document
`
`11
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`Certificate of translation of Ex. 1076: Japanese Patent Publication
`No. H08-231391, entitled “Medicine for Improvement of
`Dementia Symptoms”
`
`Folch, et al., A Simple Method for the Isolation and Purification of
`Total Lipids from Animal Tissues. J. Biol. Chem., 226, 497-509
`(1957)
`
`Declaration of Dr. Chong Lee submitted during inter partes
`reexamination of parent patent U.S. 8,030,348 (“Yeboah Reexam
`Decl.”)
`
`Declaration of Bjorn Ole Haugsgjerd in support of Inter Partes
`Review of U.S. Pat. No. 8,278,351 (“Haugsgjerd”)
`
`AKBM
`Exhibit No.
`
`1077
`
`1078
`
`1079
`
`1080
`
`
`
`
`
`
`
`
`
`
`Dated: October 1, 2013
`
`
`
`
`
`
`
`
`
`
`CASIMIR JONES SC
`2275 Deming Way, Suite 310
`Middleton, WI 53562
`(608) 662-1277
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`/John Mitchell Jones/
`John Mitchell Jones
`Registration No. 44,174
`Attorneys for Petitioner
`Registration No. 44,174
`
`
`
`
`
`
`
`12
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`
`CERTIFICATION OF SERVICE
`
`The undersigned hereby certifies that “AKER BIOMARINE AS’S
`
`EXHIBIT LIST (INTER PARTES REVIEW OF U.S. PATENT NO. 8,278,351),”
`
`along with Exhibits 1001 – 1080, were served in their entirety by United States
`
`Postal Service Express Mail No. EM656156950US this 1st day of October 2013 on
`
`the following:
`
`
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue, NW
`Suite 700
`Washington, DC 20004
`Patent owner’s correspondence address
`Of record for U.S. Patent No. 8,278,351
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CASIMIR JONES SC
`
`/John Mitchell Jones/
`John Mitchell Jones
`Registration No. 44,174
`Attorneys for Petitioner
`
`
`Dated: October 1, 2013
`
`
`
`
`
`
`
`
`
`
`
`
`2275 Deming Way, Suite 310
`Middleton, WI 53562
`(608) 662-1277
`
`
`
`
`13